Herborium Group, Inc. (HBRM)

0.0001 0.0000 (0.00%) At close: 10:20AM EDT

Herborium Group, Inc.

One Bridge Plaza North
Suite 275
Fort Lee, NJ 07024
United States
201-849-4431
https://www.herborium.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 2

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Agnes P. Olszewski	Founder, Chairman, CEO, President, CFO & Principal Accounting Officer	150k	N/A	1957
Dr. James P. Gilligan MSIB, Ph.D.	Co-Founder, Scientific Advisor & Director	66.67k	N/A	1952
Mr. Daniel Teo	Senior Vice President of Business Development	N/A	N/A	N/A
Mr. Lawrence Woo	Asia Business Advisor & Director	N/A	N/A	N/A
Mr. Roger Jones	UK & EU Advisor and Director	N/A	N/A	1943
Mr. John E. Donahue	Controller & SEC Advisor	N/A	N/A	1950

Amounts are as of 31 December 2007, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Herborium Group, Inc., a botanical therapeutics company, develops, licenses, and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. It offers dermatology products, which include AcnEase, herbal medicinal product for enhancing conditions associated with hormonal acne and multiple symptoms of Rosacea; and AcnEase Skin Management System for the treatment of acne marks/scars. The company also provides sexual health and performance products that are non-prescriptive alternatives to selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, and surgical procedures, including hysterectomy. In addition, it offers energy restoration products, such as Lasting Energy, a herbal supplement to decrease the symptoms associated with hangovers and eliminating jet-lag; and for treating overall depletion of energy due to competitive sports, high levels of stress, and extensive sexual activities, as well as other long term or temporary physical demands. Further, the company provides Liver Activator Series for the treatment of liver damage; ProstAid, a natural product focuses on Benign Prostate Hyperplasia; and CardioVitae, a fermentation based product using a Lucidium derived cell line targeting cardio-pulmonary insufficiencies. Herborium Group, Inc. sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. The company was founded in 2000 and is headquartered in Fort Lee, New Jersey.

Corporate governance

Herborium Group, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.